Japan, July 6 -- INCYTE CORP has got intellectual property rights for 'RUXOLITINIB PREPARATION FOR REDUCING ITCHINESS IN ATOPIC DERMATITIS.' Other related details are as follows:
Application Number: JP,2024-118324
Category (FI): A61K9/107,A61K31/519,A61P17/04,A61P17/00,A61K9/06,A61P37/08,A61P29/00
Stage: Grant (IP right granted following substantive examination.)
Filing Date: July 24, 2024
Publication Date: Nov. 19, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....